OR Royalties Inc. $OR Shares Sold by Louisbourg Investments Inc.

Louisbourg Investments Inc. decreased its holdings in OR Royalties Inc. (NYSE:OR) by 25.1% in the 4th quarter, HoldingsChannel reports. The fund owned 219,271 shares of the basic materials company’s stock after selling 73,600 shares during the quarter. OR Royalties comprises about 1.4% of Louisbourg Investments Inc.’s investment portfolio, making the stock its 21st biggest holding. Louisbourg Investments Inc.’s holdings in OR Royalties were worth $7,778,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Caitlin John LLC acquired a new position in shares of OR Royalties during the 3rd quarter worth $78,000. Eagle Global Advisors LLC acquired a new stake in shares of OR Royalties in the third quarter valued at about $206,000. Merit Financial Group LLC acquired a new stake in shares of OR Royalties in the third quarter valued at about $215,000. Flow Traders U.S. LLC purchased a new stake in OR Royalties during the third quarter worth about $217,000. Finally, Moors & Cabot Inc. purchased a new stake in OR Royalties during the third quarter worth about $220,000. Institutional investors and hedge funds own 68.52% of the company’s stock.

Wall Street Analysts Forecast Growth

OR has been the subject of a number of research analyst reports. Weiss Ratings reaffirmed a “buy (b)” rating on shares of OR Royalties in a report on Monday, December 29th. Wall Street Zen raised OR Royalties from a “buy” rating to a “strong-buy” rating in a research note on Saturday, March 21st. Scotiabank upped their price target on OR Royalties from $41.00 to $51.00 and gave the stock a “sector perform” rating in a report on Monday, January 26th. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of OR Royalties in a research note on Wednesday, February 4th. Finally, Zacks Research cut OR Royalties from a “strong-buy” rating to a “hold” rating in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, OR Royalties has an average rating of “Moderate Buy” and a consensus target price of $38.25.

OR Royalties Stock Up 0.4%

OR opened at $40.27 on Friday. The firm has a market cap of $7.56 billion, a P/E ratio of 36.95 and a beta of 0.83. The business’s fifty day simple moving average is $41.39 and its 200 day simple moving average is $37.95. OR Royalties Inc. has a 52 week low of $18.99 and a 52 week high of $48.06.

OR Royalties (NYSE:OR) last announced its earnings results on Wednesday, February 18th. The basic materials company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.01. The firm had revenue of $90.47 million during the quarter, compared to the consensus estimate of $90.80 million. OR Royalties had a net margin of 74.30% and a return on equity of 12.73%. As a group, equities analysts expect that OR Royalties Inc. will post 0.62 EPS for the current fiscal year.

OR Royalties Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Tuesday, March 31st will be given a $0.055 dividend. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Tuesday, March 31st. OR Royalties’s payout ratio is currently 20.18%.

OR Royalties Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.